3-32159662-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015141.4(GPD1L):c.947G>C(p.Gly316Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000692 in 1,445,228 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015141.4 missense
Scores
Clinical Significance
Conservation
Publications
- Brugada syndrome 2Inheritance: AD, Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GPD1L | ENST00000282541.10 | c.947G>C | p.Gly316Ala | missense_variant | Exon 7 of 8 | 1 | NM_015141.4 | ENSP00000282541.6 | ||
| GPD1L | ENST00000474846.5 | n.871G>C | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 | |||||
| GPD1L | ENST00000496151.1 | n.448G>C | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 | |||||
| GPD1L | ENST00000428684.1 | n.*574G>C | downstream_gene_variant | 5 | ENSP00000392199.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250908 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 6.92e-7 AC: 1AN: 1445228Hom.: 0 Cov.: 28 AF XY: 0.00000139 AC XY: 1AN XY: 720162 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Brugada syndrome Uncertain:1
This sequence change replaces glycine with alanine at codon 316 of the GPD1L protein (p.Gly316Ala). The glycine residue is moderately conserved and there is a small physicochemical difference between glycine and alanine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with GPD1L-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Cardiovascular phenotype Uncertain:1
The p.G316A variant (also known as c.947G>C), located in coding exon 7 of the GPD1L gene, results from a G to C substitution at nucleotide position 947. The glycine at codon 316 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at